M&A Deal Summary

DFW Capital Partners and Avego Healthcare Capital Acquire Saol Therapeutics

On January 2, 2017, private equity firm DFW Capital Partners and growth capital firm Avego Healthcare Capital acquired life science company Saol Therapeutics

Acquisition Highlights
  • This is DFW Capital Partners’ 5th and Avego Healthcare Capital’s 2nd transaction in the Life Science sector.
  • This is DFW Capital Partners’ 21st and Avego Healthcare Capital’s 2nd transaction in the United States.
  • This is DFW Capital Partners’ 4th and Avego Healthcare Capital’s 2nd transaction in Georgia.

M&A Deal Summary

Date 2017-01-02
Target Saol Therapeutics
Sector Life Science
Buyer(s) DFW Capital Partners
Avego Healthcare Capital
Deal Type Buyout (LBO, MBO, MBI)

Target

Saol Therapeutics

Roswell, Georgia, United States
Saol Therapeutics is a privately held specialty pharmaceutical company focused on providing therapies to patients with rare diseases. Saol Therapeutics has a strategic emphasis on the neurology therapeutic area. Saol Therapeutics was founded in 2015 and is based in Roswell, Georgia.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

DFW Capital Partners

New York, New Jersey, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1983
PE ASSETS 600M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

DFW Capital Partners is a private equity firm that invests in high-growth middle-market service companies generating revenues up to $200 million. Specific service areas of interest include business services, industrial services, and healthcare services. Prospective transactions include growth capital financing, acquisition financing, management buyouts, and recapitalization. DFW will not invest in start-ups, real estate, or pure R&D companies. DFW Capital Partners was formed in 1983 and is based in Teaneck, New Jersey.


DEAL STATS #
Overall 21 of 38
Sector (Life Science) 5 of 7
Type (Buyout (LBO, MBO, MBI)) 7 of 10
State (Georgia) 4 of 4
Country (United States) 21 of 38
Year (2017) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-12 Children s Dental Management

West Chester, Pennsylvania, United States

Children's Dental Management is a provider of quality pediatric dental care to the community for more than 40 years. With more than 20 practices and pediatric dentists located throughout the state of Pennsylvania, Children's Dental Management allows for convenient access to dental care that is engaging, fun, and educational for patients.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-02-06 Information innovators

Springfield, Vermont, United States

Information innovators, Inc. is a provider of IT services and solutions to IT and health-focused clients across the federal government. It offer a range of services including program & project management, security & information assurance, systems design & integration, telecommunications consulting and enterprise architecture support.

Sell -
DESCRIPTION

Avego Healthcare Capital is a private investment firm focused on investing in expansion stage healthcare companies. Avego has a special interest in companies that are commercializing and developing important therapeutics, medical products, and services for patients, physicians, and other customers in the US and globally. Avego Healthcare Capital was formed in 2015 and is based in Alpharetta, Georgia.


DEAL STATS #
Overall 2 of 7
Sector (Life Science) 2 of 6
Type (Buyout (LBO, MBO, MBI)) 1 of 1
State (Georgia) 2 of 3
Country (United States) 2 of 7
Year (2017) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-26 Sebela Pharmaceuticals

Roswell, Georgia, United States

Sebela Phartmaceuticals is committed to improving patients lives by developing, marketing and selling differentiated branded prescription pharmaceuticals that bring meaningful value to patients affected by gastrointestinal, dermatological and women’s health diseases. Sebela Pharmaceuticals was founded in 2013 and is based in Roswell, Georgia.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-04-16 Meridien Research

Winter Park, Florida, United States

Meridien Research is a multi-specialty clinical research site company which conducts Phase I-IV inpatient and outpatient clinical trials for global, mid-sized pharmaceutical and biotech sponsors, as well as the largest contract research organizations (“CROs”). Meridien’s research covers more than 50 indications, with the range of therapeutic areas spanning central nervous system, mental health, neurology, metabolic and endocrine disorders and women’s health. Meridien Research was founded in 2000 and is based in Winter Park, Florida.

Buy -